维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="MAUDE SL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cdk inhibition in human cells compromises chkl function and activates a DNA dam- age response显示文摘	Maude SL Enders GH	2005	Cancer Res2005，65，3：	1
2	Chimeric antigen receptor T cells for sustained remissions in leukemia显示文摘	Maude SL Frey N Shaw PA	2014	N Engl J Med2014，371，16：	1
3	Chimeric antigen receptor T cells for sustained remissions in leukemia显示文摘	Maude SL FFrey N Shaw PA	2014	N Engl J Med2014，371，16：	1
4	Chimeric antigen receptor T cells for sustained remissionsin leukemia 显示文摘	Maude SL Frey N Shaw PA	2014	N Engl J Med2014，371，16：	1
5	Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy显示文摘	Teachey DT Rheingold SR Maude SL	2013	Blood2013，121，：	1
6	T cells engineered with a chimeric antigen receptor(CAR) targeting CD19(CTL019) have long term persistence and induce durable remissions in children with relapsed,refractory ALL显示文摘	Grupp SA Maude SL Shaw P	2014	Blood2014，124，21：	1
7	Targeting JAK1/2 and mTOR in murine xenografi models of Ph-like acute lympho- blastic leukemia显示文摘	Maude SL Tasian SK Vincent T	2012	Blood2012，120，17：	1
8	Targeting 3AKlJ2 and roTOR in murine xenografl models of Ph-like acute lymphohlas- tic: leukemia显示文摘	Maude SL Tasian SK incent T	2012	Blood2012，120，17：	1
9	Managing cytokine release syndrome associated with novel T cell-engaglng therapies 显示文摘	Maude SL Barrett D Teachey DT	2014	Cancer J2014，20，2：	1
10	Chimeric antigen receptor T ceils for sustained remissions in leukemia 显示文摘	Maude SL Frey N Shaw PA	2014	N Engl J ned2014，371，16：	1
11	Chimeric antigen receptor T cells for sustained remissions in leukemia 显示文摘	Maude SL Frey N Shaw PA	2014	N Engl J Med2014，371，16：	1
12	Chimeric antigen receptor T cells for sustained remissions in leukemia显示文摘	Maude SL Frey N Shaw P A	2014	N EnglJMed2014，371，16：	1
13	Chimeric antigen re- ceptor T cells for sustained remissions in leukemia显示文摘	MAUDE SL FREY N SHAW PA	2014	N Engl J Med2014，371，16：	1
14	Targeting JAK1/2 and mTOR in murine xenograft mnodels of Ph-like acute lymphoblastic leukemia显示文摘	Maude SL Tasian SK Vincent T	2012	Blood2012，120，：	1
15	Targeting JAK1/2 and InTOR in murine xenograft models of Ph-like acute lympho- blastic leukemia显示文摘	Maude SL Tasian SK Vincent T	2012	Blood2012，120，17：	1
16	Chimeric antigen receptor T cells for sustained remissions in leukemia 显示文摘	Maude SL Frey N Shaw PA	2014	The New Eng- land journal of medicine2014，371，16：	1
17	T cells engineered with a chimeric antigen receptor ( CAR ) targeting CD19 ( CTL019 ) have long term persistence and induce durable remissions in children with relapsed, refractory ALL 显示文摘	Grupp SA Maude SL Shaw P et el	2014	Blood ( ASH annual meeting Abstracts)2014，124，21：	1
18	Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy 显示文摘	Teachey DT Rheingold SR Maude SL	2013	Blood2013，121，26：	1
19	Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy显示文摘	Teachey DT Rheingold SR Maude SL	2013	Blood2013，121，26：	1
20	Chimeric antigen receptor T cells for sustained remissions in leukemia显示文摘	Maude SL Frey N Shaw PA	2014	N Engl J Med2014，371，16：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示